DOI: 10.1055/s-00000069

Seminars in Liver Disease

References

Legendre CM, Licht C, Muus P. et al.
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.

N Engl J Med 2013;
368 (23) 2169-2181

Download Bibliographical Data

Access:
Access: